Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;60(7):828-829.
doi: 10.1002/jcph.1645. Epub 2020 May 23.

Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?

Somayyeh Nasiripour  1 , Farhad Zamani  2 , Maryam Farasatinasab  3
Affiliations

Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?

Somayyeh Nasiripour et al. J Clin Pharmacol. 2020 Jul.
No abstract available

Keywords: COVID-19; colchicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Comment in

  • Colchicine and COVID-19.
    Corral P, Corral G, Diaz R. Corral P, et al. J Clin Pharmacol. 2020 Aug;60(8):978. doi: 10.1002/jcph.1684. Epub 2020 Jun 24. J Clin Pharmacol. 2020. PMID: 32511763 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

  • Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.
    Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Williams M, Haider N, Mangat J, Hosein Z, Balendra V, Abbasi AF, Desai P, Jain I, Utulor S, Abioye A. Sanyaolu A, et al. Ther Adv Vaccines Immunother. 2022 May 30;10:25151355221097559. doi: 10.1177/25151355221097559. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35664358 Free PMC article. Review.
  • Repurposing medications.
    Novack GD. Novack GD. Ocul Surf. 2021 Jan;19:336-340. doi: 10.1016/j.jtos.2020.11.012. Epub 2020 Nov 26. Ocul Surf. 2021. PMID: 33249292 Free PMC article. No abstract available.
  • Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review.
    Khani E, Khiali S, Entezari-Maleki T. Khani E, et al. J Clin Pharmacol. 2021 Apr;61(4):429-460. doi: 10.1002/jcph.1822. Epub 2021 Mar 5. J Clin Pharmacol. 2021. PMID: 33511638 Free PMC article. Review.
  • Colchicine and COVID-19.
    Corral P, Corral G, Diaz R. Corral P, et al. J Clin Pharmacol. 2020 Aug;60(8):978. doi: 10.1002/jcph.1684. Epub 2020 Jun 24. J Clin Pharmacol. 2020. PMID: 32511763 Free PMC article. No abstract available.
  • COVID-19 management in patients with comorbid conditions.
    Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Balendra V, Lehachi A, Abbasi AF, Haider N, Abioye A, Orish VN, Antonio A, Badaru O, Pandit R, Izurieta R. Sanyaolu A, et al. World J Virol. 2025 Jun 25;14(2):102674. doi: 10.5501/wjv.v14.i2.102674. World J Virol. 2025. PMID: 40575645 Free PMC article. Review.
See all "Cited by" articles

References

    1. World Health Organization . Coronavirus disease 2019 (COVID‐19): situation report‐67. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed March 27, 2020.
    1. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033‐1034. - PMC - PubMed
    1. Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188‐195. - PMC - PubMed
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497‐506. - PMC - PubMed
    1. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID‐19 based on an analysis of data of 150 patients from Wuhan, China [published online ahead of print March 3, 2020]. Intensive Care Med. doi: 10.1007/s00134-020-05991-x. - DOI - PMC - PubMed